Final answer:
The Clinical Studies section of a package insert provides information on the drug's effectiveness, inactive ingredients, cancer risk, and controlled substance classification.
Step-by-step explanation:
The information found in the Clinical Studies section of the package insert includes:
- How well a drug works for its approved indications: This section provides data on the effectiveness of the drug in treating the specific conditions it is approved for.
- A drug's inactive ingredients: The package insert lists all the inactive ingredients present in a drug formulation.
- A drug's cancer risk: If a drug has been associated with an increased risk of developing cancer, this information will be included in the Clinical Studies section.
- A drug's-controlled substance classification: If a drug is classified as a controlled substance, this information will also be provided in this section.